TransCode Therapeutics, Inc.
RNAZ
$1.78
-$0.11-5.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.38M | 12.84M | 17.81M | 2.84M | 7.37M |
| Total Receivables | 600.00 | 600.00 | 953.10K | 198.30K | 176.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 95.60K | 239.40K | 318.00K | 476.20K | 90.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.16M | 3.67M | 2.90M | 1.24M | 600.00K |
| Total Current Assets | 10.64M | 16.75M | 21.98M | 4.75M | 8.24M |
|
|
|||||
| Total Current Assets | 10.64M | 16.75M | 21.98M | 4.75M | 8.24M |
| Net Property, Plant & Equipment | 322.80K | 346.70K | 370.70K | 19.90K | 24.70K |
| Long-term Investments | 25.74M | 25.74M | 25.74M | -- | -- |
| Goodwill | 25.74M | 25.74M | 25.74M | -- | -- |
| Total Other Intangibles | 114.30M | 114.30M | 114.30M | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 25.00K | -- | 455.70K | -- |
| Total Assets | 151.01M | 157.16M | 162.40M | 5.23M | 8.27M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 4.68M | 5.29M | 3.49M | 2.97M | 1.57M |
| Short-term Debt | 652.40K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 63.90K | 85.30K | -- | -- | -- |
| Total Other Current Liabilities | 63.90K | 85.30K | -- | -- | -- |
| Total Current Liabilities | 5.40M | 5.38M | 3.49M | 2.97M | 1.57M |
|
|
|||||
| Total Current Liabilities | 5.40M | 5.38M | 3.49M | 2.97M | 1.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 652.40K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.25M | 7.27M | 7.02M | 832.90K | 553.70K |
| Total Liabilities | 12.65M | 12.64M | 10.52M | 3.80M | 2.12M |
|
|
|||||
| Common Stock & APIC | 94.70M | 116.90M | 108.20M | 85.85M | 85.71M |
| Retained Earnings | -122.40M | -115.65M | -97.86M | -84.42M | -79.56M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -27.70M | 1.25M | 10.34M | 1.43M | 6.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 166.05M | 143.27M | 141.54M | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 166.05M | 143.27M | 141.54M | -- | -- |
|
|
|||||
| Total Common Equity | -27.70M | 1.25M | 10.34M | 1.43M | 6.15M |
| Total Preferred Equity | 166.05M | 143.27M | 141.54M | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 138.36M | 144.52M | 151.88M | 1.43M | 6.15M |
|
|
|||||